Here, we elucidated the mechanism of Gyp in non-alcoholic steatohepatitis (NASH) with a focus on farnesoid X receptor (FXR)-mediated bile acid and lipid metabolic pathways. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.